EGFR and breast cancer: Liang et al. revealed that RGS16 protein expression is upregulated in breast cancer cells and inhibits the activation of the PI3K signaling pathway via epidermal growth factor receptor (EGFR), thereby suppressing the proliferation of breast cancer cells (Liang et al., 2009).